00:00 AM UTC/GMT+2
23:59 AM UTC/GMT+3
of IASGO in İstanbul
With the developing health technology, transplant oncology has become one of the prominent areas in the treatment of cancer diseases, especially hepatobiliary system (HPB). Transplant oncology is a field that aims to maximize the treatment and quality of life of hepatobiliary system cancer patients. One of the current themes of the 33rd IASGO Turkey congress, which will be held in Istanbul this year, will be “transplant oncology”.
The main steps that make up the essence of transplant oncology; surgery, transplantation and oncology. Transplant oncology, which emerged as a result of a multidisciplinary approach in HPB cancers, is a promising cancer treatment concept. Therefore, one of the main topics to be discussed in the congress; “Limits and future of transplant oncology”. Transplant oncology focuses on the treatment with liver transplantation in primary and metastatic hepatobiliary system cancers, and HPB cancer treatment processes have been advanced with transplant oncology. World-renowned experts in the fields of transplantation, radiology, oncology, hepatology and immunology will come together with IASGO Turkey to share their innovative surgical research and case studies on the basis of transplant oncology, and contribute to the scientific efforts of physicians who want to improve themselves.
Looking at the post-treatment data, it appears that transplant oncology makes a significant contribution to the overall survival rate in many cases. For this reason, the overall survival success rates in current transplant oncology cases will also be evaluated in scientific sessions. At the 33rd IASGO Turkey congress transplant oncology scientific sessions, the latest literature information and clinical experiences on personalized treatment processes will be presented by the speakers.
Immunotherapy, which is one of the new systemic treatment methods of cancer, is one of the innovative treatment approaches whose primary aim is to prolong the life quality and life expectancy of patients. Today, the immunotherapy method used in cancer cases has brought a new direction to cancer treatment. In the scientific sessions of the 33rd IASGO Turkey congress, the subject of immunotherapy will be discussed in detail with the theme of new treatments that can be applied in local and advanced cancers.
The use of immunotherapy in hepatopancreatobiliary system (HPB) cancers has become increasingly important in recent years. In congress scientific sessions; Parameters such as the selection of appropriate patient profiles for immunotherapy, new immunotherapy treatment protocols that affect the healing process, and the results of adjuvant treatment in metastatic cancers will be highlighted. With the participation of experts experienced in the fields of oncology and cancer surgery, immunotherapy treatment and positive and negative effects results in clinical cancer cases will be presented to health professionals.
Combining immunotherapy methods in suitable patients in addition to classical cancer treatments provides promising results. The overall survival and progression-free survival rates will be evaluated with objective updated data in cases treated with immunotherapy within the scope of the congress. IASGO Turkey, which will take place for the 33rd time in Istanbul this year, will be a pioneering congress with its strong scientific program that also aims to create large-scale international Clinical Trial study groups and to design prospective studies on immunotherapy treatment.
At the 33rd IASGO World Congress, promising new treatments in gastrointestinal system cancers will be discussed by the speakers, surgeons and oncologists who are continuing clinical experimental studies around the world. In scientific sessions, current information on diagnosis, treatment and postoperative period in gastrointestinal system cancers and the latest treatment approaches in gastrointestinal system cancers will be discussed.
In order to establish the correct diagnosis and staging in GI tract cancers, a personalized protocol should be followed. Personalized treatment is a very important parameter for GI oncology. For this reason, current developments in GI oncology sessions will be shared with patient-specific approaches and the implementation of universal standards of diagnosis and treatment.
The primary importance of comprehensive evaluation in gastrointestinal system cancers will also be emphasized.
In GI oncology scientific sessions, studies on developments in systemic therapy, changing practices, neoadjuvant therapy, possible side effects and follow-ups, and management of side effects will be presented. Multidisciplinary case discussions in GI oncology will also be at the center of this scientific session. Scientific research in gastrointestinal malignancies will be one of the topics to be covered at the 33rd IASGO World Congress, where data on diagnosis and treatment processes will be shared with up-to-date methods and holistic approaches.
Metabolic and bariatric surgery, liver transplantation, robotic and laparoscopic surgery, colorectal surgery, hepato pancreato biliary surgery, cytoreductive surgery, immunotherapy, transplant oncology and gastrointestinal system oncology, which are the main topics of IASGO World Congress, which will be held for the 33rd time this year, will be discussed multidisciplinary. In addition, it is aimed to convey the most up-to-date information to the participants with the Clinical Trial sessions, rich and exciting scientific program content.
Sessions involving multidisciplinary clinical studies at the 33rd IASGO Turkey congress to be held in Istanbul with the participation of hundreds of scientists; question-answer, discussion, and evaluation of real case examples. Scientific sessions, in which multidisciplinary clinical studies will take place, will guide physicians in making the distinction between patients in the diagnosis process and the right treatment planning for the purpose, and the importance of the interdisciplinary correlation process will be demonstrated once again.
Laparoscopic surgery, which is frequently used in general surgery operations, is a preferred operation technique with its advantages such as localization, rapid recovery, less pain in the postoperative period, less infection, smaller incision, and early initiation of oral intake. Laparoscopic surgery, which is one of the scientific session topics of the 33rd IASGO World Congress, will be one of the important topics where many current case discussions such as recovery after laparoscopic surgery and basic information such as instruments in laparoscopic surgery, anesthesia in laparoscopic surgery will be held.
Patient satisfaction is gradually increasing in the laparoscopic surgery process, which provides similar therapeutic results by providing cosmetic advantages with special techniques that avoid laparotomy. For this reason, in this scientific title, the serious benefits of laparoscopic surgery, which is used in the diagnosis and treatment stages, will be given to the patient and the surgeon, and studies that show that it is a safe laparoscopic method will be presented. In addition to the advantages of laparoscopic surgery, indications for laparoscopic surgery and contraindications for laparoscopic surgery will be discussed in detail in this scientific session with important names in the field.
One of the topics that will be discussed under the main heading of laparoscopic surgery at the 33rd IASGO World Congress, which will be held in Istanbul this year, will be modern surgical techniques that are used or will be used in laparoscopy surgery with the latest medical technology innovations.
Robotic surgery, which is the most advanced point reached by the world of surgery, is a method used in the treatment of many branches and diseases, providing many benefits to the surgeon and the patient with the advantage of 3D imaging depth. Robotic surgery, the last step of advanced technology in surgery, will be discussed in detail with the themes of "what is robotic surgery" and "how to do robotic surgery" in the scientific sessions of the IASGO World Congress, which will take place for the 33rd time this year. This minimally invasive treatment method will be evaluated interactively with the presentations of surgeons experienced in robotic surgery techniques and discussions on the advantages and disadvantages of robotic surgery. Robotic surgery case analyses in Turkey will be presented with the latest updated data, and "how to do robotic surgery" with the latest techniques will be discussed through sample cases by the physicians who are speakers at the robotic surgery scientific session. The basic principles of successful operations performed by preserving the functional and anatomical structure with robotic surgery, which includes many advantages such as minimal complications with small incisions, three-dimensional detailed image, fast healing, fine and precise movement ability thanks to articulated instruments, and surgical ergonomics will be explained. Today, robot technology, which is used more frequently in surgeries, is one of the most up-to-date topics in the robotic medicine world. Philosophy and technical application information will be conveyed in order to better understand the robotic surgery system, which is an important health technology product, and to increase its use in surgeries; Scientific content and practical training will be provided to improve the experience of surgeons using the robotic surgery system. At the 33rd IASGO World Congress, which will be held with case sharing in the form of a robotic surgery course and a course participation certificate will be given, the latest developments in robotic surgery, which is a closed surgery technology, will be discussed in the sessions.
The prevalence of liver cancer continues to increase rapidly and is one of the most important health problems requiring liver transplantation. The success of our country in liver transplantation has increased every year and has reached a point which we can say is above the world standards. In the 33rd IASGO World Congress liver transplantation scientific sessions, information will be presented on basic and current topics such as liver diseases, treatment approaches to liver diseases, liver transplantation conditions, liver transplantation surgery, how liver transplantation happens, intensive care after liver transplantation, life after liver transplantation. Management of diagnosis and treatment processes through real patient profiles with liver transplantation will be evaluated together with all participants.
Specific issues to be considered in the preoperative period, such as liver transplant donor risks and liver transplant donor preparation, will also be addressed in scientific sessions. Specialist surgeons attending the congress as speakers will share their lives and cadaver liver transplant statistics and up-to-date information with the participants, revealing Turkey's success in liver transplantation. Liver transplantation experiences of Turkey will be presented with case examples and interactive discussions will be provided after the liver transplantation data presented by participants from abroad. The 33rd IASGO World Congress will be a scientific panel where research on liver diseases and liver transplantation will be detailed and the results of these researches will be evaluated by the participants.
One of the main topics of the 33rd IASGO World Congress will be the scientific titles of "bariatric surgery and metabolic surgery", which cover the diagnosis and treatment processes of two important diseases, such as obesity and diabetes, whose prevalence is increasing day by day. Bariatric surgery and metabolic surgery are still the most important treatment options for the treatment of obesity, which is an important health problem, and concomitant diseases such as diabetes mellitus.
Bariatric surgery and metabolic surgery, which have gained significant momentum in the field of general surgery in recent years, have come to an important point both in our country and in the world. Within the scope of the congress, the beginning topics of "how to do bariatric surgery" and "how to do metabolic surgery" will contribute to the education of young surgeons by covering the processes of bariatric surgery and metabolic surgery step by step with a projection of the past, present and future of medical treatment in obesity.
Surgical workshops will provide information on choosing the right patient and method in bariatric and metabolic surgery by specialist physicians. The 33rd IASGO World Congress will be a congress where complications and revisional surgery in metabolic and bariatric surgery will be discussed in scientific sessions. The obesity treatment process will be covered in detail with the presentations of physicians experienced in bariatric surgery indications and solutions.
A multidisciplinary approach in bariatric and metabolic surgery is a very important point in the treatment of obesity. At the 33rd IASGO World Congress, where multidisciplinary teamwork, which is the primary rule in the surgical protocol, will be emphasized under a separate title, current issues related to life after bariatric surgery will be discussed with case follow-ups. Ongoing studies on nutrition after metabolic and bariatric surgery will also be actively evaluated.
Surgery is still at the forefront in the treatment of colorectal cancer, which is the third most common type of cancer worldwide. The colorectal surgery scientific sessions of the 33rd IASGO World Congress and the surgical methods applied in the treatment of colon and rectum cancers will be examined under many headings. In the congress, the cases operated with the diagnosis of colorectal cancer will be presented and discussed in the light of the current literature. Participants will have the chance to compare colon and rectum surgeries in terms of many different criteria such as number, diversity, morbidity, complications, and healing process through sample cases.
Information on anatomy in colorectal surgery, pathology for colorectal surgeons, colonoscopy in early diagnosis, techniques in colorectal surgery, the contribution of innovations in medical treatment to colorectal surgery, and screening programs will also be shared. Studies on basic subjects such as preoperative staging and patient selection for surgery will be covered under the heading of surgery in the treatment of colon and rectal cancer. Speakers will present their research on new trends in colorectal surgery, which we can define as a dynamic branch of medicine, and new methods in diagnosis and treatment processes in scientific sessions. The 33rd IASGO World Congress colorectal surgery scientific sessions, where the colon and rectal region operations will be evaluated, will be held with a multidisciplinary approach, including current topics such as laparoscopic colorectal surgery and robotic colorectal surgery. Curious issues such as technology and safety in robotic and laparoscopic colorectal surgery will also be among the important points highlighted in the panels.
Today, the main center of many diseases is the gastrointestinal tract (GIS). With its high incidence rates, upper gastrointestinal system diseases are one of the main subjects of general surgery. Every year, there are many new approaches to the diagnosis and treatment of upper gastrointestinal diseases, with the effect of epidemiological research and developing health technology. Therefore, one of the important topics of the 33rd IASGO World Congress scientific sessions will be upper gastrointestinal surgery.
Upper gastrointestinal system diseases and cancers are important health problems that cause high mortality and morbidity. The first topics of the scientific session will be the diagnostic approach to upper gastrointestinal system cancers, differential diagnosis criteria for upper GIS cancers, and measures for the patient's vital functions. New research on upper gastrointestinal endoscopy will also be presented by general surgeons attending the congress.
Upper gastrointestinal surgery, which remains indispensable in the treatment of upper gastrointestinal diseases, is one of the important themes of the congress. Topics such as surgical treatment for upper gastrointestinal system bleeding and indications for surgical treatment will also be discussed in congress sessions in the light of case studies. Laparoscopic and robotic surgery, which can be safely applied like open surgery, and treatment methods in upper gastrointestinal diseases will be discussed interactively at the congress with multidisciplinary approaches. With the scientific research presentations and training panels of surgeons experienced in this field, upper gastrointestinal surgery will be covered under a wide range of current topics at the 33rd IASGO World Congress, which will take place this year.
Hepatopancreatobiliary surgery (HPB), which focuses on the treatment of liver, gallbladder, biliary tract and pancreatic diseases and adopts a multidisciplinary approach, is gaining increasing importance. New developments in surgical methods with advancing technology also affect hepato-pancreato-biliary surgical approaches. Within the scope of IASGO World Congress, the 33rd of which will take place this year, hepato pancreato biliary surgery will be evaluated on an up-to-date and broad scientific basis.
Diseases of the gallbladder, biliary tract, pancreas and liver are on the rise in our country. In this scientific session of our congress, topics such as developments in the diagnostic methods of hepato-pancreato-biliary diseases and basic principles in hepato-pancreato-biliary surgery will be covered in detail with presentations and workshops. Clinical status data of HPB diseases and current studies in the treatment of hepato-pancreato-biliary diseases will also be included in the program. In addition, interactive sessions will be held to discuss minimally invasive techniques of hepato-pancreato-biliary surgery and changes in medical technology. This scientific session, which will continue with different approaches and opinions in hepato-pancreato-biliary surgical treatment, will also pave the way for the formation of new perspectives among hepato-pancreato-biliary surgeons.
Hepato-pancreato-biliary surgery, which covers the surgical treatment of gallbladder, biliary tract, liver and pancreatic diseases, is a dynamic and special field with its complicated medical processes. Hepato-pancreato-biliary surgery will be one of the important topics of the 33rd IASGO World Congress with the participation of many experienced local and foreign surgeons.
Cytoreductive surgery (SRC) is a treatment approach that offers very successful results in terms of survival in selected patients. Cytoreductive surgery in advanced-stage intra-abdominal cancer will be one of the main topics of the 33rd IASGO World Congress. In the scientific sessions of the congress, the basic criteria in cytoreductive surgery, which is a series of organ resection and peritonectomy procedures, will be presented with the current literature. Specialist surgeons participating in the congress, while conveying their knowledge on the subject of "How should the appropriate patient selection be?" in cytoreductive surgery, will also explain important technical details under this scientific title of "complete cytoreduction", that is, total gross tumor removal. One of the important topics to be discussed during this meeting, which will bring together many healthcare professionals experienced in HIPEC and PIPAC treatment, is “To whom and how are HIPEC and PIPAC applied?”. The application of HIPEC and PIPAC chemotherapy methods after cytoreductive surgery is a revolution in the treatment of peritoneal cancer. In this scientific session, HIPEC and PIPAC intra-abdominal chemotherapy treatments applied together with cytoreductive surgery in advanced-stage intra-abdominal cancer cases where the multidisciplinary approach is primary will be discussed in detail. Surgeons presenting at the 33rd IASGO World Congress will also share their knowledge and experience on the effects of SRC, HIPEC and PIPAC treatments on improving the quality of life and prolonging life in peritoneal cancer cases, through case studies.